Literature DB >> 6816925

Growth of isolated amastigotes of Trypanosoma cruzi in cell-free medium.

F Villalta, F Kierszenbaum.   

Abstract

Amastigotes of Trypanosoma cruzi were purified from overlays of infected Vero cell cultures by centrifugation over a discontinuous gradient of metrizamide. Pure amastigote preparations were usually recovered from the pellet under the layer of specific gravity 1.086. The isolated amastigotes grew in cell-free ML-15HA medium. Growth rate for the different strains of T. cruzi were in the order Y greater than Tulahuen greater than CL. The generation time of amastigotes in ML-15HA medium was 16.8, 18.0 and 26.4 h for the Y, Tulahuen, and CL strains, respectively, in the presence of 5% CO2, and 16.8, 31.2, and 36.4 h, respectively, in the absence of CO2. Intracellular amastigotes did not differ ultrastructurally from amastigotes from either the density-gradient fractionation or culture in cell-free medium.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6816925     DOI: 10.1111/j.1550-7408.1982.tb01338.x

Source DB:  PubMed          Journal:  J Protozool        ISSN: 0022-3921


  14 in total

1.  Structural insights into inhibition of sterol 14alpha-demethylase in the human pathogen Trypanosoma cruzi.

Authors:  Galina I Lepesheva; Tatiana Y Hargrove; Spencer Anderson; Yuliya Kleshchenko; Vyacheslav Furtak; Zdzislaw Wawrzak; Fernando Villalta; Michael R Waterman
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

2.  Transforming growth factor alpha binds to Trypanosoma cruzi amastigotes to induce signaling and cellular proliferation.

Authors:  A Deloris Alexander; Fernando Villalta; Maria F Lima
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

3.  Molecular cloning of a Trypanosoma cruzi cell surface casein kinase II substrate, Tc-1, involved in cellular infection.

Authors:  Swinburne A J Augustine; Yuliya Y Kleshchenko; Pius N Nde; Siddharth Pratap; Edward A Ager; James M Burns; Maria F Lima; Fernando Villalta
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Novobiocin antagonism of amastigotes of Trypanosoma cruzi growing in cell-free medium.

Authors:  P G Pate; J S Wolfson; G L McHugh; S C Pan; M N Swartz
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

5.  CYP51: A major drug target in the cytochrome P450 superfamily.

Authors:  Galina I Lepesheva; Tatyana Y Hargrove; Yuliya Kleshchenko; W David Nes; Fernando Villalta; Michael R Waterman
Journal:  Lipids       Date:  2008-09-04       Impact factor: 1.880

Review 6.  Cultivation of clinically significant hemoflagellates.

Authors:  Frederick L Schuster; James J Sullivan
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

7.  Arginine decarboxylase inhibitors reduce the capacity of Trypanosoma cruzi to infect and multiply in mammalian host cells.

Authors:  F Kierszenbaum; J J Wirth; P P McCann; A Sjoerdsma
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

8.  Interaction of human eosinophils or neutrophils with Trypanosoma cruzi in vitro causes bystander cardiac cell damage.

Authors:  H A Molina; F Kierszenbaum
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

9.  Effects of IL-4 on macrophage functions: increased uptake and killing of a protozoan parasite (Trypanosoma cruzi).

Authors:  J J Wirth; F Kierszenbaum; A Zlotnik
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

10.  Fibronectin increases Trypanosoma cruzi amastigote binding to and uptake by murine macrophages and human monocytes.

Authors:  E L Noisin; F Villalta
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.